Clinical Trials on Gram-Positive Bacterial Infections in Australia
Total 253 results
-
GPN VaccinesRecruitingSafety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.Pneumococcal InfectionsAustralia
-
GPN VaccinesRecruiting
-
Valneva Austria GmbHCompletedClostridium Difficile InfectionAustria, Hungary
-
The University of QueenslandWithdrawn
-
PfizerCompletedGram-negative Bacterial InfectionAustralia
-
Menzies School of Health ResearchWorld Health Organization; Universidade da PazCompleted
-
Menzies School of Health ResearchThe University of Queensland; Australasian Society for Infectious Diseases; Singapore... and other collaboratorsTerminatedMethicillin-Resistant Staphylococcus AureusAustralia, New Zealand, Israel, Singapore
-
Astellas Pharma Europe Ltd.Cubist Pharmaceuticals LLCTerminatedClostridium DifficileSpain, France, Germany, Greece, Denmark, Austria, Poland
-
PfizerCompletedBacterial Infections | Staphylococcal Skin Infections | Staphylococcal Infections | Staphylococcal Vaccines | Immunotherapy, ActiveAustralia
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedLatent Tuberculosis InfectionCanada, Australia, Benin, Brazil, Ghana, Guinea, Indonesia
-
Savara Inc.CompletedMycobacterium Infections, NontuberculousAustralia, United Kingdom
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedLatent Tuberculosis InfectionCanada, Australia, Benin, Brazil, Ghana, Indonesia, Guinea, Korea, Republic of, Saudi Arabia
-
Centers for Disease Control and PreventionBritish Medical Research CouncilRecruitingLatent TuberculosisAustralia, United States, Canada, South Africa
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionUnited States, Australia, Belgium, Chile, Germany, Korea, Republic of, New Zealand, Puerto Rico, Sweden, Taiwan, Turkey
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionUnited States, Australia, Canada, Chile, Japan, Korea, Republic of, New Zealand, Poland
-
Western Sydney Local Health DistrictCentre Of Research Excellence in Tuberculosis ControlRecruitingTuberculosis, PulmonaryAustralia
-
PfizerCompletedClostridium Difficile InfectionUnited States, Spain, Belgium, Taiwan, Japan, Portugal, Colombia, Korea, Republic of, Poland, Australia, Germany, Canada, Argentina, Bulgaria, Chile, Czechia, Finland, France, Hungary, Peru, Slovakia, Sweden, United Kingdom
-
Ellume Pty LtdCompletedGroup A Streptococcal InfectionAustralia
-
GlaxoSmithKlineCompleted
-
Astellas Pharma Europe Ltd.Merck Sharp & Dohme LLCCompletedClostridium DifficileGreece, Spain, Russian Federation, Denmark, Austria, Belgium, Croatia, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Poland, Portugal, Romania, Slovenia, Sweden, Switzerland, Turkey, United Kingdom
-
Clifford Craig Medical Research TrustJohns Hopkins Bloomberg School of Public Health; Monash University; University... and other collaboratorsUnknownHeterologous Effects of VaccinesAustralia
-
GlaxoSmithKlineTerminatedTetanus | Diphtheria | Acellular PertussisAustralia
-
PfizerCompletedPneumococcal DiseaseDenmark, Belgium, Australia, Poland, Norway, Finland, Netherlands, Italy, Czechia, Estonia, Russian Federation, Slovakia
-
ActelionCompletedClostridium Difficile InfectionUnited States, Australia, Brazil, Canada, France, Germany, Italy, Netherlands, Peru, Poland, Romania, Spain
-
Sanofi Pasteur, a Sanofi CompanyTerminatedClostridium Difficile InfectionSweden, United States, Mexico, Philippines, Singapore, Germany, France, Canada, Australia, Peru, Colombia, Brazil, Costa Rica, Denmark, Dominican Republic, Finland, Guatemala, Japan, Korea, Republic of, Panama, Poland, Puerto Rico, ... and more
-
The University of QueenslandMerck Sharp & Dohme LLCWithdrawnBacteremia Caused by Gram-Negative BacteriaSpain, Australia, Singapore, Italy, Saudi Arabia
-
Summit TherapeuticsCompletedClostridioides Difficile InfectionUnited States, Australia, Greece, Canada, Spain, Brazil, Poland, Korea, Republic of, Argentina, Bulgaria, Hungary, New Zealand, Romania, Russian Federation
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, Australia, Belgium, Brazil, Canada, Colombia, France, Germany, Mexico, Sweden
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsAustralia, Belgium, Czechia, Estonia, Germany, Greece, Poland, Russian Federation, Spain
-
University Medical Center GroningenUnknownTuberculosis, Multidrug-ResistantSweden, United Kingdom, Australia, Belarus, Brazil, Greece, Italy, Latvia, Mexico, Netherlands, Portugal, South Africa, Tanzania
-
Insmed IncorporatedCompletedMycobacterium Infections, NontuberculousUnited States, Argentina, Australia, Austria, Canada, Chile, Denmark, Germany, Israel, Italy, Korea, Republic of, New Zealand, Spain, Taiwan
-
Menzies School of Health ResearchMurdoch Childrens Research Institute; University of Melbourne; Cooperative Research...CompletedStreptococcal Infections | Scabies | Pyoderma | ImpetigoAustralia
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, Australia, Canada, Finland, Germany, Israel, Malaysia, Peru, Taiwan, Thailand
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, Australia, Canada, Chile, New Zealand, Poland, Russian Federation
-
Royal Brisbane and Women's HospitalThe University of QueenslandCompletedGram-Negative Bacterial InfectionsAustralia
-
Insmed IncorporatedRecruitingMycobacterium Infections, NontuberculousBelgium, New Zealand, United Kingdom, United States, Argentina, Australia, Austria, Canada, Chile, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Poland, Spain, Taiwan, Turkey, Portugal
-
University of AdelaideSA HealthCompletedMeningococcal DiseaseAustralia
-
Merck Sharp & Dohme LLCActive, not recruitingPneumococcal DiseaseArgentina, Australia, Colombia, Germany, Israel, Korea, Republic of, New Zealand, Spain, Taiwan, Turkey, United Kingdom
-
Tuberculosis Network European TrialsgroupCompletedTuberculosis | Monitoring, ImmunologicDenmark, United Kingdom, Sweden, Australia, Bulgaria, Germany, Greece, Italy, Netherlands, Portugal, Romania, Spain, Switzerland, Turkey
-
GlaxoSmithKlineCompletedTetanus | Diphtheria | Acellular Pertussis | Diphtheria-Tetanus-acellular Pertussis VaccinesAustralia
-
University of AdelaideCompletedMeningococcal Infections | Neisseria Infection | Neisseria Meningitis SepsisAustralia
-
Menzies School of Health ResearchNational Health and Medical Research Council, AustraliaCompletedPneumococcal Infections | Tympanic Membrane Perforation | Acute Otitis Media | Middle Ear EffusionAustralia
-
Merck Sharp & Dohme LLCCompletedPneumococcal DiseaseUnited States, Austria, Canada, Denmark, Finland, Israel, Poland, Spain
-
University of MelbourneRadboud University Medical Center; Sunnybrook Health Sciences Centre; UMC Utrecht and other collaboratorsRecruitingStaphylococcus Aureus BacteremiaAustralia, New Zealand, Canada, Singapore, Netherlands, Israel
-
Andrew SteerNational Health and Medical Research Council, Australia; Queen Fabiola Children... and other collaboratorsCompletedBacterial Infections | Gram-Positive Bacterial Infections | Strep Throat | Streptococcus Pharyngitis | Streptococcus Pyogenes Pharyngitis | Streptococcus Pyogenes Infection | Group A Streptococcus: B Hemolytic Pharyngitis | Group A Streptococcal InfectionAustralia
-
GlaxoSmithKlineCompleted
-
University of MelbourneNational Health and Medical Research Council, Australia; Menzies School of...UnknownPneumococcal Infections | Tympanic Membrane Perforation | Acute Otitis Media | Middle Ear EffusionAustralia
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedMeningitis, MeningococcalAustralia
-
Astellas Pharma Europe Ltd.CompletedInflammatory Bowel Disease (IBD) | Clostridium Difficile Infection (CDI)Austria, France, Greece, Italy, Poland, Russian Federation, United Kingdom